APA
Burton B. K., Grange D. K., Milanowski A., Vockley G., Feillet F., Crombez E. A., Abadie V., Harding C. O., Cederbaum S., Dobbelaere D., Smith A. & Dorenbaum A. (20071025). The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. : Journal of inherited metabolic disease.
Chicago
Burton B K, Grange D K, Milanowski A, Vockley G, Feillet F, Crombez E A, Abadie V, Harding C O, Cederbaum S, Dobbelaere D, Smith A and Dorenbaum A. 20071025. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. : Journal of inherited metabolic disease.
Harvard
Burton B. K., Grange D. K., Milanowski A., Vockley G., Feillet F., Crombez E. A., Abadie V., Harding C. O., Cederbaum S., Dobbelaere D., Smith A. and Dorenbaum A. (20071025). The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. : Journal of inherited metabolic disease.
MLA
Burton B K, Grange D K, Milanowski A, Vockley G, Feillet F, Crombez E A, Abadie V, Harding C O, Cederbaum S, Dobbelaere D, Smith A and Dorenbaum A. The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study. : Journal of inherited metabolic disease. 20071025.